The comment is that organizations like research hospitals need to be responsible for moving these forward. We have some scientists who are good entrepreneurs, who can raise money, who come up with the idea, and have taken products straight through to being sold in the clinic—the little blue pill. It takes a long time, but it has happened. We have other scientists who have come up with an amazing discovery that we know is the basis of a platform technology that will have commercial venture. They're not interested in going any further on that. We find the people, then, who can take it further because we don't want to let that technology fail. Again, there's not one size that fits all in this industry.
On May 21st, 2013. See this statement in context.